Magzter GOLDで無制限に

Magzter GOLDで無制限に

10,000以上の雑誌、新聞、プレミアム記事に無制限にアクセスできます。

$149.99
 
$74.99/年

試す - 無料

PLEDGED YOUR HOUSE AS A LOAN COLLATERAL? CHECK THIS

Mint Mumbai

|

September 25, 2025

For most Indians, a home is far more than a roof over their heads—it represents stability, security and aspiration.

- ANUJ SHARMA

With the expansion of housing finance across income segments, more families have begun leveraging their property as collateral for credit access. Though it can be empowering — unlocking lower interest rates and longer tenures—it carries a big risk: if repayments falter, the pledged home can be repossessed.

Safeguarding your asset needs more than optimism. It demands discipline, regulatory awareness and careful planning.

The Reserve Bank of India has long recognized that over-leveraging against property can be dangerous. To mitigate this, it enforces strict loan-to-value caps.

Bankscan lend up to 90% of the property value for loans of ₹30 lakh or less, 80% for ₹30-₹75 lakh, and 75% for above ₹75 lakh. Stamp duty and registration costs are excluded from this calculation, except for low-value units below ₹10 lakh.

This ensures borrowers always contribute equity, creating a crucial safety buffer. This means if your home is worth ₹50 lakh, you can expect financing of about ₹40 lakh at most. While this can feel burdensome for first-time buyers, the design is intentional: It prevents households from falling into the trap of excessive debt if property values stagnate or incomes decline.

Mint Mumbai からのその他のストーリー

Mint Mumbai

Mint Mumbai

Gen Alpha will make new rules for their workplace

Gen Alpha will expect hybrid workplaces, Al tools and 4-day weeks— offices unrecognizable to their parents’

time to read

3 mins

December 01, 2025

Mint Mumbai

EC extends electoral roll revision by a week to II Dec; final list on 14 Feb

The Election Commission on Sunday extended by one week the entire schedule of the ongoing special intensive revision (SIR) of electoral rolls in nine states and three Union territories amid allegations by opposition parties that the “tight timelines” were creating problems for people and ground-level poll officials.

time to read

2 mins

December 01, 2025

Mint Mumbai

THE PROBLEM IS NOT JUST ABOUT DYNASTIC POLITICS

These days Tejashvi Yadav is the target of intense trolling. Before him the Huda family in Haryana and Thackerays in Maharashtra got the same treatment. So, is the battle of victory and defeat in electoral politics a tussle between dynasts vs the rest? Absolutely not.

time to read

3 mins

December 01, 2025

Mint Mumbai

Mint Mumbai

Green hydrogen: Fast fashion could help bump up demand

A boom in its use for clean synthetic inputs might make a difference

time to read

3 mins

December 01, 2025

Mint Mumbai

Let's be a bit more selective in using the word 'reforms'

Everybody should take a beat and think before uttering the word ‘reforms’ the next time. Glib usage, frequently in the wrong context, threatens to rob the word of its import.

time to read

3 mins

December 01, 2025

Mint Mumbai

As mid-cap alpha shrinks, should you consider passive strategies?

Advisers urge a balanced mix—add passives slowly and back strong, active managers, as mid-caps are still pricey

time to read

4 mins

December 01, 2025

Mint Mumbai

Mint Mumbai

With $2.2 bn fund, ChrysCap has appetite for riskier bets

MD Saurabh Chatterjee details shift in global LP base, renewed focus on manufacturing

time to read

3 mins

December 01, 2025

Mint Mumbai

GDP growth of 8% plus: How to sustain this pace

Last quarter's economic expansion has cheered India but the challenge is to sustain a brisk rate for years to come. For private investment to chip in, revive infrastructure partnerships

time to read

2 mins

December 01, 2025

Mint Mumbai

INSIDE INDIA'S ATTEMPT TO TAME DEEPFAKES

Detection tools today are not universal or consistent across languages

time to read

5 mins

December 01, 2025

Mint Mumbai

Mint Mumbai

APIs to innovation: Bulk drug makers ramp up CDMO bets

Once focused on low-margin active pharmaceutical ingredients (APIs), India’s bulk drug manufacturers are raising their ambitions, with several now investing heavily in research and development to win contract development and manufacturing work from global drugmakers.

time to read

2 mins

December 01, 2025

Listen

Translate

Share

-
+

Change font size